Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas

被引：0

作者：

Braunstein, Zachary ^{[1
]}

Waller, Allyson ^{[2
]}

Dotson, Emily ^{[3
]}

McLaughlin, Eric ^{[4
]}

Hanel, Walter ^{[5
]}

Reneau, John C. ^{[5
]}

Addison, Daniel ^{[6
]}

Porcu, Pierluigi ^{[7
]}

Brammer, Jonathan E. ^{[5
]}

机构：

[1] Ohio State Univ, James Canc Hosp, Wexner Med Ctr, Columbus, OH USA

[2] Ohio State Univ, Ctr Comprehens Canc, Dept Pharm, Columbus, OH USA

[3] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA

[4] Ohio State Univ, Ctr Biostat, Columbus, OH USA

[5] Ohio State Univ, Wexner Med Ctr, James Canc Ctr, Columbus, OH USA

[6] Ohio State Univ, Dept Cardiol, Wexner Med Ctr, Columbus, OH USA

[7] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184583

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas
Braunstein, Zachary
Waller, Allyson
Dotson, Emily
McLaughlin, Eric
Hanel, Walter
Reneau, John
Addison, Daniel
Porcu, Pierluigi
Brammer, Jonathan Edward
LEUKEMIA & LYMPHOMA, 2024, 65 (03) : 301 - 311
[2] Gemcitabine, Navelbine, and Doxorubicin as Treatment for Patients with Refractory or Relapsed T-Cell Lymphoma
Qian, Zhengzi
Song, Zheng
Zhang, Huilai
Wang, Xianhuo
Zhao, Jing
Wang, Huaqing
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[3] Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
Rapkin, Louis
Qayed, Muna
Brill, Pam
Martin, Melissa
Clark, Dana
George, Bradley A.
Olson, Thomas A.
Wasilewski-Masker, Karen
Alazraki, Adina
Katzenstein, Howard M.
PEDIATRIC BLOOD & CANCER, 2012, 59 (05) : 854 - 858
[4] Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas
Pulini, Stefano
Rupoli, Serena
Goteri, Gaia
Pimpinelli, Nicola
Alterini, Renato
Tassetti, Angela
Scortechini, Anna Rita
Offidani, Massimo
Mulattieri, Simonetta
Stronati, Andrea
Brandozzi, Giuliano
Giacchetti, Alfredo
Mozzicafreddo, Giorgio
Ricotti, Giuseppe
Filosa, Giorgio
Bettacchi, Alberta
Simonacci, Marco
Novelli, Nicolino
Leoni, Pietro
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (05): : 686 - 689
[5] Pegylated liposomal doxorubicin (Doxil®) is active in the treatment of relapsed/refractory lymphomas.
Tulpule, A
Justice, G
Espina, BM
Harvey-Buchanan, L
Barut, L
Khan, A
Levine, AM
BLOOD, 1998, 92 (10) : 241B - 241B
[6] Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas
Huang, Ling
Jiang, Xinmiao
Li, Wenyu
Guo, Hanguo
Wei, Xiaojuan
Liu, Sichu
Chen, Feili
Liang, Zhanli
BLOOD, 2020, 136
[7] Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
Barta, Stefan K.
Fowler, Nathan H.
Zain, Jasmine
Ruan, Jia
Smith, Sonali M.
Schuster, Stephen J.
Nasta, Sunita D.
Svoboda, Jakub
Gerson, James N.
Landsburg, Daniel J.
Chong, Elise A.
Fung, Henry C.
Campbell, Kerry S.
Khan, Nadia
Fisher, Richard I.
Tan, Carlyn Rose
BLOOD, 2019, 134
[8] Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Zinzani, Pier Luigi
Bonthapally, Vijayveer
Huebner, Dirk
Lutes, Richard
Chi, Andy
Pileri, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 228 - 240
[9] Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
Zinzani, Pier Luigi
Bonthapally, Vijayveer
Huebner, Dirk
Lutes, Richard
Chi, Andy
Pileri, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 214 - 227
[10] Gemcitabine, oxaliplatin and dexamethasone (GemDOx) as salvage therapy for relapsed or refractory diffuse large B-cell lymphoma and peripheral T-cell lymphoma
Shen, Qiu-Dan
Wang, Li
Zhu, Hua-Yuan
Liang, Jin-Hua
Xia, Yi
Wu, Jia-Zhu
Fan, Lei
Li, Jian-Yong
Xu, Wei
JOURNAL OF CANCER, 2021, 12 (01): : 163 - 169

← 1 2 3 4 5 →